In a 13D filing after the close, the Harvard Management Company disclosed owning 2,240,000 shares of Teavana, or 5.77% of the outstanding shares. All the shares were acquired after the merger was announced on November 14th.

On that date, Starbucks announced that it would acquire Teavana for $15.50 per share in cash. However, shares of Teavana have traded at a significant discount to the offer price on allegations from Glaucus Research that Starbucks will walk away from the deal on claims that the company is misleading customer about its claims that its teas are pesticide free.